Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D3 and Nicotine in Rats Via Targeting TNF-α, IL-1β, iNOS, and Osteogenic Runx2 Ahmed E. AmerGeorge S. G. ShehatouAhmed R. El-Sheakh Original Article 26 July 2021 Pages: 1047 - 1059
K-80003 Inhibition of Macrophage Apoptosis and Necrotic Core Development in Atherosclerotic Vulnerable Plaques Xiaolei WangZhe SunBen He Original Article Open access 19 August 2021 Pages: 1061 - 1073
Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation Li WangYunfan PengYongjian Wang Original Article 26 August 2021 Pages: 1075 - 1089
SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes Huan ChenYochai BirnbaumYumei Ye Original Article 27 August 2021 Pages: 1091 - 1108
HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm Xing ZhangAnyi WangYanbin Huang Original Article 07 September 2021 Pages: 1109 - 1119
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events John Maret-OudaGiola SantoniJesper Lagergren Original Article Open access 09 July 2021 Pages: 1121 - 1128
Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study Petr ToušekTomáš LazarákViktor Kočka Original Article Open access 10 September 2021 Pages: 1129 - 1136
The Prognostic Impact of Anti-thrombotic Treatment Strategies After Biological Aortic Valve Replacement Andreas HammerFelix HoferPatrick Sulzgruber Original Article 10 September 2021 Pages: 1137 - 1145
Influence of Moxonidine and Bisoprolol on Morphofunctional Condition of Arterial Wall and Telomerase Activity in Postmenopausal Women with Arterial Hypertension and Osteopenia. The Results from a Moscow Randomized Study E. DudinskayaO. TkachevaV. Larina Original Article 15 September 2021 Pages: 1147 - 1155
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure Michele CorrealePietro MazzeoNatale Daniele Brunetti Original Article Open access 14 September 2021 Pages: 1157 - 1164
Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19 Daein ChoiQinzhong ChenRobert S. Rosenson Original Article 15 September 2021 Pages: 1165 - 1173
Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study Nicholas J. MontarelloKuljit SinghPeter J. Psaltis Trial Designs 25 August 2021 Pages: 1175 - 1186
Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection Juan Antonio Requena-IbáñezCarlos G. Santos-GallegoJuan José Badimon Invited Review Article 17 September 2021 Pages: 1187 - 1196
Challenges in Optimizing Lipid Management in Women Kellsey A. PetersonGurleen KaurRadmila Lyubarova Invited Review Article 18 October 2021 Pages: 1197 - 1220
Do We Really Need Aspirin Loading for STEMI? Regina YeHani JneidYochai Birnbaum Invited Review Article 16 February 2022 Pages: 1221 - 1238
Dual Anti-platelet Therapy After Transcatheter Aortic Valve Implantation: Double Trouble? Faisal RahmanWaleed T. KayaniHani Jneid Editorial 22 November 2021 Pages: 1239 - 1241
Is Aspirin Loading Before Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction Necessary? Hiroshi AsanumaMasafumi Kitakaze Editorial 20 January 2022 Pages: 1243 - 1245
The application of proton pump inhibitors in cardiovascular disease needs to be individualized Xi-Liang WangJia-Hui LiuDe-Gang Mo Letter to the Editor 22 October 2022 Pages: 1247 - 1248
Reassessment of Confidence in a Network Meta-analysis of Antidysrhythmic Drugs for Atrial Fibrillation Cardioversion Ian S. deSouzaRobert AllenPragati Shrestha Letter to the Editor 25 January 2022 Pages: 1249 - 1251
Pharmacologic Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department in the Novel Anticoagulants’ Era Dimitris TsiachrisIoannis DoundoulakisKonstantinos Tsioufis Letter to the Editor 26 February 2022 Pages: 1253 - 1254
Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19 Laurent ChouchanaNathanaël Beekeron behalf of AP-HP/Universities/Inserm COVID-19 research collaboration, AP-HP Covid CDR Initiative, and “Entrepôt de Données de Santé” AP-HP Consortium Correction 04 March 2021 Pages: 1255 - 1255
Correction to: Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease Florian KrackhardtMatthias WaliszewskiMichel Pansieri Correction Open access 22 July 2022 Pages: 1257 - 1258
Correction to: The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus Bertram PittGabriel StegDeepak L. Bhatt Correction 24 December 2021 Pages: 1259 - 1259
Correction to: A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions Xue YuXinyue WangFang Wang Correction 12 April 2021 Pages: 1261 - 1262
